Prof. Dr. Murat Yılmaz İç Hastalıkları Endokrinoloji ve Metabolizma Hastalıkları Uzmanı olarak hastalarına kendi özel muayenehanesinde hizmet vermektedir.
T. Arınsoy, M. Yılmaz, Ö. Ataoğlu, M. Bali, Ş. Sindel, Castleman’s Disease with renalamyloidosis and nephrotic syndrome, Nephrol Dial Trans, 12, 2713-2716 (1997).
T Arınsoy, M.Yılmaz, Ü. Derici, Ş. Sindel, İ. Tekin , E. Hasanoğlu,Prevalance of Hepatitis E Virus antibody in hemodialysis patients, Nephron, 80,85 (1998)
İ Yetkin, G. Ayvaz , M. Arslan, M. Yılmaz, N. Çakır, “A case of Costello syndrome with endocrine features”, Ann. Genet, 41, 157-160 (1998)
U Öztok, M. Yılmaz , A.Karakoç, N. Çakır, A.E. Karakaya , S. Sardaş, Oxidative DNA damage by Comet assay in diabetic patients, Neoplasma, 5, 195-199 (1999)
S. Sardaş, M. Yılmaz , U.Öztok, N Çakır, ve A.E. Karakaya, Assesment of DNA strand breakage by Comet assay in diabetic patients and the role of antioxidant, Mutation Research, 490 123-129 (2001)
A Karakoc, G. Ayvaz, F. Taneri, F. Törüner, M. Yılmaz, N. Çakır, M.Arslan, The effects of hypothyroidism in rats on serum leptin concentrations and leptin mRNA levels in adipose tissue and relationship with body fat composition, Endocr Res, 30, 247-255 (2004)
. M Yılmaz, A.Biri, N. Bukan, A. Karakoç, B. Sancak, F. Törüner, H. Paşaoğlu, Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome, Gynecol. Endocrinol., 20, )
M Yılmaz N. Bukan, R.Ersoy, A. Karakoç, İ. Yetkin, G. Ayvaz, N. Çakır, M. Arslan, Glucose intolerance, insulin resistance and cardiovascular risk factors in first degree relatives of women with polycystic ovary syndrome. Hum. Reprod., 20, )
M Yılmaz, A. Karakoç, F.B. Törüner, N, Çakır, B.Tıras, G. Ayvaz, M. Arslan, The effects of rosiglitazone and metformin on menstrual cyclicity and hirsutism in polycystic ovary syndrome. Gynecol. Endocrinol., 21,154-160 (2005
M Yılmaz. A. Biri, A. Karakoç, F.Törüner, B.Bingöl, N.Çakır, B. Tıraş, G.Ayvaz, M. Arslan, The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome, J. Endocrinol. Invest., 28, 1003-1008,2005
. B Nazliel, M Yılmaz, B Kocer, I Yetkin, Z Yesilbudak. Event related potentials in hypothyroidism. Electromyogr Clin Neurophysiol. 48:203-8. (2008
. E Yurtcu, A Yılmaz, Z Ozkurt, E Kolukisa, M Yılmaz, H Keles, MA Ergun, I Yetkin, A Menevse.Melanocortin-4 receptor gene polymorphisms in obese patients. Biochem Genet. 47: )
. H Demirci, M Yılmaz, MA Ergun, E Yurtçu, N Bukan, G Ayvaz. Frequency of adiponectin gene polymorphisms in polycystic ovary syndrome and the association with serum adiponectin, androgen levels, insulin resistance and clinical parameters.Gynecol Endocrinol. 26:348-55. (2010
. C Celik , R Abali , N Tasdemir , S Guzel , A Yuksel , E Aksu , M.Yılmaz. Is subclinical hypothyroidism contributing dyslipidemia and insulin resistance in women with polycystic ovary syndrome? Gynecol Endocrinol. 28:615-8 (2012
. Celik C, Abali R, Güzel S , Bastu E , Kucukyalcin V , Yılmaz M. Elevated circulating levels of YKL-40 are a marker of abnormal glucose tolerance in women with polycystic ovary syndrome.Clin Endocrinol (Oxf). May 14. (2012
Guzel EC, Celik C, Abali R, Kucukyalcin V, Celik E, Guzel M, Yilmaz M.Omentin and chemerin and their association with obesity in women with polycystic ovary syndrome.Gynecol Endocrinol. 2014 30(6):419-2
Yavuz DG, Bilen H, Sancak S, Garip T, Hekimsoy Z, Sahin I, Yilmaz M, Aydin H, Atmaca A, Sert M, Karakaya P, Arpaci D, Oguz A, Guvener N. Impact of telephonic interviews on persistence and daily adherence to insulin treatment in insulin-naïve type 2 diabetes patients: dropout study. Patient Prefer Adherence. 2016 May 17;10:851-61
. Sonmez A, Haymana C, Bayram F, Salman S, Dizdar OS, Gurkan E, Kargili Carlıoglu A, Barcin C, Sabuncu T, Satman I; TEMD Study Group. Turkish nationwide survEy of glycemic and other Metabolic parameters of patients with Diabetes mellitus (TEMD study). Diabetes Res Clin Pract. 2018 Dec;146:138-147
. Sonmez A, Yumuk V, Haymana C, Demirci I, Barcin C, Kıyıcı S, Güldiken S, Örük G, Ozgen Saydam B, Baldane S, Kutlutürk F, Küçükler FK, Deyneli O, Çetinarslan B, Sabuncu T, Bayram F, Satman I Impact of Obesity on the Metabolic Control of Type 2 Diabetes: Results of the Turkish Nationwide Survey of Glycemic and Other Metabolic Parameters of Patients with Diabetes Mellitus (TEMD Obesity Study). ; TEMD Study Group. Obes Facts. 2019;12(2):167- 178
Patterns and preferences of antidiabetic drug use in Turkish patients with type 2 diabetes - A nationwide cross-sectional study (TEMD treatment study). Haymana C, Sonmez A, Demirci I, Fidan Yaylalı G, Nuhoglu I, Sancak S, Yilmaz M, Altuntas Y, Dinccag N, Sabuncu T, Bayram F, Satman I; TEMD Study Group.Diabetes Res Clin Pract. 2021 Jan;171:
Bayram F, Sonmez A, Haymana C, Sabuncu T, Dizdar OS, Gurkan E, Carlioglu AK, Agbaht K, Ozdemir D, Demirci I, Barcin C, Salman S, Tetiker T, Balci MK, Kebapci N, Ersoy C, Yumuk V, Toth PP, Satman I Utilization of statins and LDL-cholesterol target attainment in Turkish patients with type 2 diabetes - a nationwide cross-sectional study (TEMD dyslipidemia study).; TEMD Study Group.Lipids Health Dis. 2020 Nov 11;19(1):237
.Demirci I, Haymana C, Salman S, Tasci I, Corapcioglu D, Kirik A, Yetkin İ, Altay M, Sabuncu T, Bayram F, Satman I, Sonmez A; TEMD Study Group Rates and associates ofinfluenza and pneumococcus vaccination in diabetes mellitus: A nationwide crosssectionalstudy(TEMD vaccination study). World J Diabetes. 2021 Dec 15;12(12):2107-2118.
Ş Dumlu, M. Bali, M. Yılmaz, Ş. Sindel, C.Tuncer, E.Hasanoğlu, Prevalance of gallstone disease in hemodialysis patients, Nephron, 78,347-348 (1998).
